Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean N DaSilva

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|March 12, 2009
Cardiovascular drug development using radiopharmaceuticalsHeikki Ukkonen, Keiichiro Yoshinaga, Jean N DaSilva, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|January 9, 2020
Radiosynthesis of the <sup>11</sup> C-methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitrilValentin R Teyssier, José-Mathieu Simard, Mark H Dornan, et al.
Life Sciences|May 3, 2015
Insulin therapy normalizes reduced myocardial β-adrenoceptors at both the onset and after sustained hyperglycemia in diabetic ratsJames M Haley, James T Thackeray, Maria Kolajova, et al.
European Journal of Pharmacology|January 14, 2003
Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatmentsRobert A Schwartz, Eric R Greenwald, Paul J Fletcher, et al.
Current Radiopharmaceuticals|December 24, 2011
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipramMiran Kenk, Adam Thomas, Mireille Lortie, et al.
EJNMMI Research|June 25, 2016
Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartanBasma Ismail, Robert A deKemp, Tayebeh Hadizad, et al.
Nuclear Medicine and Biology|May 17, 2008
Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissuesMiran Kenk, Michael Greene, Mireille Lortie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Single-phase CT aligned to gated PET for respiratory motion correction in cardiac PET/CTR Glenn Wells, Terrence D Ruddy, Rob A DeKemp, et al.
Bioorganic & Medicinal Chemistry|November 3, 2009
Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in ratsTayebeh Hadizad, Sheryn A Kirkpatrick, Samantha Mason, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomographyJean N DaSilva, Celia M Lourenco, Jeffrey H Meyer, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|March 12, 2009
Cardiovascular drug development using radiopharmaceuticalsHeikki Ukkonen, Keiichiro Yoshinaga, Jean N DaSilva, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|January 9, 2020
Radiosynthesis of the <sup>11</sup> C-methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitrilValentin R Teyssier, José-Mathieu Simard, Mark H Dornan, et al.
Life Sciences|May 3, 2015
Insulin therapy normalizes reduced myocardial β-adrenoceptors at both the onset and after sustained hyperglycemia in diabetic ratsJames M Haley, James T Thackeray, Maria Kolajova, et al.
European Journal of Pharmacology|January 14, 2003
Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatmentsRobert A Schwartz, Eric R Greenwald, Paul J Fletcher, et al.
Current Radiopharmaceuticals|December 24, 2011
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipramMiran Kenk, Adam Thomas, Mireille Lortie, et al.
EJNMMI Research|June 25, 2016
Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartanBasma Ismail, Robert A deKemp, Tayebeh Hadizad, et al.
Nuclear Medicine and Biology|May 17, 2008
Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissuesMiran Kenk, Michael Greene, Mireille Lortie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Single-phase CT aligned to gated PET for respiratory motion correction in cardiac PET/CTR Glenn Wells, Terrence D Ruddy, Rob A DeKemp, et al.
Bioorganic & Medicinal Chemistry|November 3, 2009
Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in ratsTayebeh Hadizad, Sheryn A Kirkpatrick, Samantha Mason, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomographyJean N DaSilva, Celia M Lourenco, Jeffrey H Meyer, et al.
Pageof 8